AP2006003768A0 - TetraazabenzoÄeÜazulene derivatives and analogs tehereof - Google Patents
TetraazabenzoÄeÜazulene derivatives and analogs tehereofInfo
- Publication number
- AP2006003768A0 AP2006003768A0 AP2006003768A AP2006003768A AP2006003768A0 AP 2006003768 A0 AP2006003768 A0 AP 2006003768A0 AP 2006003768 A AP2006003768 A AP 2006003768A AP 2006003768 A AP2006003768 A AP 2006003768A AP 2006003768 A0 AP2006003768 A0 AP 2006003768A0
- Authority
- AP
- ARIPO
- Prior art keywords
- tetraazabenzoäeüazulene
- tehereof
- analogs
- derivatives
- tetraazabenzoäeüazulene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57403304P | 2004-05-25 | 2004-05-25 | |
| PCT/IB2005/001469 WO2005116034A1 (fr) | 2004-05-25 | 2005-05-13 | Derives de tetraazabenzo[e]azulene et analogues de ceux-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2006003768A0 true AP2006003768A0 (en) | 2006-10-31 |
Family
ID=34967684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2006003768A AP2006003768A0 (en) | 2004-05-25 | 2005-05-13 | TetraazabenzoÄeÜazulene derivatives and analogs tehereof |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7265104B2 (fr) |
| EP (1) | EP1753766A1 (fr) |
| JP (1) | JP4069159B2 (fr) |
| CN (1) | CN1950374A (fr) |
| AP (1) | AP2006003768A0 (fr) |
| AR (1) | AR049187A1 (fr) |
| AU (1) | AU2005247693A1 (fr) |
| BR (1) | BRPI0510273A (fr) |
| CA (1) | CA2568056A1 (fr) |
| CR (1) | CR8753A (fr) |
| EA (1) | EA010888B1 (fr) |
| EC (1) | ECSP067025A (fr) |
| GE (1) | GEP20094723B (fr) |
| GT (1) | GT200500119A (fr) |
| IL (1) | IL178220A0 (fr) |
| MA (1) | MA28605B1 (fr) |
| NL (1) | NL1029105C2 (fr) |
| NO (1) | NO20064288L (fr) |
| PA (1) | PA8634101A1 (fr) |
| PE (1) | PE20060363A1 (fr) |
| SV (1) | SV2006002127A (fr) |
| TN (1) | TNSN06386A1 (fr) |
| TW (1) | TWI297688B (fr) |
| UA (1) | UA84208C2 (fr) |
| UY (1) | UY28915A1 (fr) |
| WO (1) | WO2005116034A1 (fr) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060177438A1 (en) * | 2005-02-08 | 2006-08-10 | New England Medical Center | Methods of altering absorption of hydrophobic compounds |
| WO2007028394A2 (fr) * | 2005-09-08 | 2007-03-15 | Gastrotech Pharma A/S | Utilisation d'une molecule glp-1 pour le traitement de la dyskinesie biliaire et/ou d'une douleur ou d'une gene biliaire |
| CA2666193A1 (fr) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Imidazolidin-2,4-dione arylaminoaryl-alkyl-substituee, son procede de fabrication, medicament contenant ce compose et son utilisation |
| JP2010509392A (ja) | 2006-11-13 | 2010-03-25 | ファイザー・プロダクツ・インク | ジアリール、ジピリジニルおよびアリール−ピリジニル誘導体ならびにその使用 |
| EP2102201B1 (fr) * | 2006-12-11 | 2010-10-13 | Merck Sharp & Dohme Corp. | Sulfonamides de diazépine substitués utilisés en tant que modulateurs des récepteurs de sous-type 3 de la bombésine |
| EP2131657A1 (fr) * | 2007-02-28 | 2009-12-16 | Merck & Co., Inc. | Benzodiazépinones, benzoxazépinones et benzothiazépinones substituées en tant que bloqueurs de canaux sodiques |
| WO2009050720A1 (fr) * | 2007-10-15 | 2009-04-23 | Inventis Dds Pvt Limited | Composition pharmaceutique d'orlistat |
| EP2214481B1 (fr) | 2007-10-15 | 2019-05-01 | United Animal Health, Inc. | Procédé permettant d'accroître la performance d'une progéniture |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| BRPI0921110A2 (pt) * | 2008-11-13 | 2016-02-16 | Hoffmann La Roche | espiro-5,6-di-hidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos |
| AU2009317386B2 (en) * | 2008-11-18 | 2013-07-25 | F. Hoffmann-La Roche Ag | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
| CN102227428B (zh) * | 2008-11-28 | 2015-03-25 | 弗·哈夫曼-拉罗切有限公司 | 用作加压素via受体拮抗剂的二氢四氮杂苯并薁的芳基环己基醚 |
| WO2010067233A1 (fr) | 2008-12-08 | 2010-06-17 | Pfizer Inc. | 1,2,4 triazolo[4,3-a][1,5] benzodiazépin-5(6h)-ones utilisées comme agonistes du récepteur de la cholécystokinine-1 (cck-1r) |
| WO2010068601A1 (fr) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant |
| EP2389374A1 (fr) | 2009-01-20 | 2011-11-30 | Pfizer Inc. | Pyrazinone amides substitués |
| TW201038580A (en) | 2009-02-02 | 2010-11-01 | Pfizer | 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives |
| TW201040174A (en) | 2009-02-03 | 2010-11-16 | Pfizer | 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one derivatives |
| EP2393811A1 (fr) | 2009-02-04 | 2011-12-14 | Pfizer Inc. | Dérivés de 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one |
| CA2754681C (fr) | 2009-03-11 | 2014-01-07 | Pfizer Inc. | Derives de benzofuranyle utilises comme inhibiteurs de la glucokinase |
| WO2010103438A1 (fr) | 2009-03-11 | 2010-09-16 | Pfizer Inc. | Indazole amides substitués |
| CA2754523A1 (fr) | 2009-03-20 | 2010-09-23 | Pfizer Inc. | 3-oxa-7-azabicyclo[3,3.1]nonanes |
| PE20120399A1 (es) | 2009-06-05 | 2012-04-24 | Pfizer | Derivados del l-(piperidin-4-il)-pirazol como moduladores de gpr 119 |
| MX2012001729A (es) | 2009-08-26 | 2012-06-13 | Sanofi Sa | Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo. |
| WO2011036576A1 (fr) | 2009-09-23 | 2011-03-31 | Pfizer Inc. | Modulateurs de gpr 119 |
| WO2011051864A1 (fr) | 2009-11-02 | 2011-05-05 | Pfizer Inc. | Dérivés dioxa-bicyclo[3.2.1]octane-2,3,4-triol |
| ES2444543T3 (es) | 2009-11-10 | 2014-02-25 | Pfizer Inc | Inhibidores de la N1-pirazoloespirocetona acetil-CoA carboxilasa |
| WO2011058473A1 (fr) | 2009-11-10 | 2011-05-19 | Pfizer Inc. | Inhibiteurs de n2-pyrazolospirocétone acétyl-coa carboxylase |
| US20120295845A1 (en) | 2009-11-23 | 2012-11-22 | Pfizer Inc | Imidazo-pyrazoles as gpr119 inhibitors |
| US20110160143A1 (en) * | 2009-12-28 | 2011-06-30 | Perricone Nicholas V | Topical Acyl Glutathione Psoriasis Compositions |
| JP5496409B2 (ja) | 2010-03-19 | 2014-05-21 | ファイザー・インク | ２，３ジヒドロ−１ｈ−インデン−１−イル−２，７−ジアザスピロ［３．５］ノナン誘導体およびグレリン受容体のアンタゴニストまたは逆アゴニストとしてのそれらの使用 |
| TW201201813A (en) | 2010-03-31 | 2012-01-16 | Arqule Inc | Substituted benzo-pyrido-triazolo-diazepine compounds |
| US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
| US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
| US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
| WO2011158149A1 (fr) | 2010-06-18 | 2011-12-22 | Pfizer Inc. | Dérivés de 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one |
| US8859577B2 (en) | 2010-09-30 | 2014-10-14 | Pfizer Inc. | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
| ES2546465T3 (es) | 2010-10-29 | 2015-09-23 | Pfizer Inc | Inhibidores de N1/N2-lactama acetil-CoA carboxilasa |
| AU2011346670B2 (en) | 2010-12-23 | 2015-05-07 | Pfizer Inc. | Glucagon receptor modulators |
| CA2825102C (fr) | 2011-02-08 | 2016-03-08 | Pfizer Inc. | Modulateur du recepteur de glucagon |
| JP2014511382A (ja) * | 2011-02-23 | 2014-05-15 | コエルルウス リミテッド | フルマゼニル錯体、それを含む組成物、およびその使用 |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| WO2012120058A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120051A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés benzyl-oxathiazine substitués avec adamantane ou noradamantane, médicaments contenant ces composés et leur utilisation |
| WO2012120053A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation |
| EP2683702B1 (fr) | 2011-03-08 | 2014-12-24 | Sanofi | Nouveaux dérivés de phényle-oxathiazine substitués, leur procédé de fabrication, médicament contenant ces liaisons et son utilisation |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683700B1 (fr) | 2011-03-08 | 2015-02-18 | Sanofi | Dérivés d'oxathiazine tétra-substitués, leur procédé de fabrication, leur utilisation comme médicament ainsi que médicaments en étant pourvu et leur utilisation |
| WO2012120052A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
| WO2012143813A1 (fr) | 2011-04-22 | 2012-10-26 | Pfizer Inc. | Dérivés de pyrazolospirocétone destinés à être utilisés comme inhibiteurs d'acétyl-coa carboxylase |
| CA2841757A1 (fr) | 2011-07-15 | 2013-01-24 | Etzer Darout | Modulateurs de gpr 119 |
| AU2012288493B2 (en) | 2011-07-22 | 2015-08-06 | Pfizer Inc. | Quinolinyl glucagon receptor modulators |
| ES2605565T3 (es) | 2011-08-31 | 2017-03-15 | Pfizer Inc | Compuestos de hexahidropirano [3,4-D][1,3]tiazin-2-amina |
| EP2567959B1 (fr) | 2011-09-12 | 2014-04-16 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
| HK1206735A1 (en) | 2012-04-06 | 2016-01-15 | 辉瑞公司 | Diacylglycerol acyltransferase 2 inhibitors |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| WO2013164730A1 (fr) | 2012-05-04 | 2013-11-07 | Pfizer Inc. | Composés d'hexahydropyrano[3,4-d][1,3]thiazin-2-amine substitués par des hétérocycliques à titre d'inhibiteurs d'app, bace1 et bace2 |
| EP3255049A1 (fr) | 2012-06-29 | 2017-12-13 | Pfizer Inc | Nouvelles 7h-pyrrolo[2,3-d]pyrimidines substituées par un groupe amino en position 4, utilisées comme inhibiteurs de lrrk2 |
| US9260455B2 (en) | 2012-09-20 | 2016-02-16 | Pfizer Inc. | Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds |
| EP2931731A1 (fr) | 2012-12-11 | 2015-10-21 | Pfizer Inc. | Composés d'hexahydropyrano [3,4-d][1,3]thiazin-2-amine en tant qu'inhibiteurs de bace1 |
| JP6162820B2 (ja) | 2012-12-19 | 2017-07-12 | ファイザー・インク | 炭素環式および複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物 |
| CA2897678A1 (fr) | 2013-02-13 | 2014-08-21 | Pfizer Inc. | Composes hexahydropyrano [3,4-d][1,3] thiazin-2-amine substitues par un heteroaryle |
| US9233981B1 (en) | 2013-02-15 | 2016-01-12 | Pfizer Inc. | Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds |
| JP6348582B2 (ja) | 2013-10-09 | 2018-06-27 | ファイザー・インク | プロスタグランジンｅｐ３受容体の拮抗薬 |
| CN103664675B (zh) * | 2013-11-27 | 2016-05-18 | 浙江省诸暨合力化学对外贸易有限公司 | 一种2-氯-n-(4-氟苯基)-n-异丙基乙酰胺的制备方法 |
| ES2663622T3 (es) | 2013-12-17 | 2018-04-16 | Pfizer Inc. | Novedosas 1H-pirrolo[2,3-b]piridinas 3,4-disustituidas y 7H-pirrolo[2,3-c]piridacinas 4,5-disustituidas como inhibidores de LRRK2 |
| DK3119757T3 (en) | 2014-03-17 | 2018-06-18 | Pfizer | DIACYLGYLERIC-ACYL TRANSFERASE-2 INHIBITORS TO USE IN THE TREATMENT OF METABOLIC AND RELATED DISEASES |
| CN106459088A (zh) | 2014-04-10 | 2017-02-22 | 辉瑞公司 | 2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺 |
| WO2016092413A1 (fr) | 2014-12-10 | 2016-06-16 | Pfizer Inc. | Composés indoliques et indazoliques qui activent l'ampk |
| EP3237401B1 (fr) | 2014-12-22 | 2019-03-06 | Pfizer Inc | Antagonistes de récepteur ep3 de prostaglandine |
| PT3766885T (pt) | 2015-06-17 | 2022-08-09 | Pfizer | Compostos tricíclicos e a sua utilização como inibidores de fosfodiesterase |
| MX377305B (es) | 2015-09-14 | 2025-03-07 | Pfizer | DERIVADOS DE IMIDAZO[4,5-c]QUINOLINA E IMIDAZO[4,5-c][1,5]NAFTIRIDINA NOVEDOSOS COMO INHIBIDORES DE LRRK2. |
| AU2016325665A1 (en) | 2015-09-24 | 2018-03-08 | Pfizer Inc. | N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides |
| WO2017051303A1 (fr) | 2015-09-24 | 2017-03-30 | Pfizer Inc. | Dérivés de tétrahydropyrano[3,4-d] [1,3]oxazine et leur utilisation en tant qu'inhibiteurs de bace |
| WO2017051294A1 (fr) | 2015-09-24 | 2017-03-30 | Pfizer Inc. | N-[2-(3-amino-2,5-diméthyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides utiles comme inhibiteurs de bace |
| US9809579B2 (en) | 2015-12-29 | 2017-11-07 | Pfizer Inc. | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
| CN105524069A (zh) * | 2016-02-25 | 2016-04-27 | 江苏理工学院 | 一种新型胆囊收缩毒受体拮抗剂类似物及其合成方法 |
| AR109179A1 (es) | 2016-08-19 | 2018-11-07 | Pfizer | Inhibidores de diacilglicerol aciltransferasa 2 |
| TWI718644B (zh) | 2018-08-31 | 2021-02-11 | 美商輝瑞股份有限公司 | 用於治療ｎａｓｈ／ｎａｆｌｄ和相關疾病之組合 |
| EP3972596B1 (fr) | 2019-05-20 | 2025-07-16 | Pfizer Inc. | Combinaisons comprenant du benzodioxol en tant qu'agonistes de glp-1r destinées à être utilisées dans le traitement de la nash/nafld et de maladies associées |
| MX2022004142A (es) | 2019-10-07 | 2022-09-21 | Kallyope Inc | Agonistas de gpr119. |
| HUE068174T2 (hu) | 2020-02-07 | 2024-12-28 | Gasherbrum Bio Inc | Heterociklusos GLP-1 agonisták |
| TW202140440A (zh) | 2020-02-28 | 2021-11-01 | 美商克力歐普股份有限公司 | Gpr40激動劑 |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
| CN112573494B (zh) * | 2020-12-23 | 2022-06-21 | 西南石油大学 | 一种利用水合物法的氦精制装置 |
| US20250066337A1 (en) | 2021-08-26 | 2025-02-27 | Pfizer Inc. | Amorphous Form of (S)-2-(5-((3-Ethoxypyridin-2-YL)Oxy)Pyridin-3-YL)-N-(Tetrahydrofuran-3-YL)Pyrimidine-5-Carboxamide |
| WO2023169456A1 (fr) | 2022-03-09 | 2023-09-14 | Gasherbrum Bio , Inc. | Agonistes hétérocycliques de glp-1 |
| EP4508047A1 (fr) | 2022-04-14 | 2025-02-19 | Gasherbrum Bio, Inc. | Agonistes hétérocycliques de glp-1 |
| WO2024118524A1 (fr) | 2022-11-28 | 2024-06-06 | Cerevel Therapeutics, Llc | Composés d'azaindole et leur utilisation en tant qu'inhibiteurs de phosphodiestérase |
| AU2023396387A1 (en) | 2022-12-15 | 2025-06-26 | Gasherbrum Bio, Inc. | Salts and solid forms of a compound having glp-1 agonist activity |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2318673A1 (de) * | 1973-04-13 | 1974-11-07 | Boehringer Sohn Ingelheim | Neue substituierte triazolo-1,5benzodiazepine |
| IE41197B1 (en) | 1973-05-29 | 1979-11-07 | Squibb & Sons Inc | 4h-s-triazolo (4,3-a)(1,5)benzodiazepin-5-ones |
| US4080323A (en) * | 1977-03-07 | 1978-03-21 | Hoffmann-La Roche Inc. | Imidazo [1,5-a][1,5] benzodiazepines |
| US4118386A (en) | 1977-04-04 | 1978-10-03 | Hoffmann-La Roche Inc. | Synthesis of imidazo[1,5-a]diazepine-3-carboxylates |
| CA1146866A (fr) | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Procede de production d'un compose pharmaceutique a liberation continue sous forme solide |
| DE3438830A1 (de) | 1984-10-23 | 1986-04-30 | Rentschler Arzneimittel | Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung |
| ATE159426T1 (de) | 1991-04-16 | 1997-11-15 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer festen dispersion |
| US5340591A (en) | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
| JP3265680B2 (ja) | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
| GB9307833D0 (en) * | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
| FR2716195B1 (fr) | 1994-02-14 | 1996-06-21 | Sanofi Sa | Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| EP0756602B1 (fr) | 1994-04-14 | 1999-06-30 | Glaxo Wellcome Inc. | 5-heterocyclo-1,5-benzodiazepines modulant les effets de la chol ecystokinine ou de la gastrine |
| PE27497A1 (es) * | 1994-04-15 | 1997-08-07 | Glaxo Inc | Derivados de 1,5 benzodiazepina |
| DE19504832A1 (de) | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
| PT901786E (pt) | 1997-08-11 | 2007-08-07 | Pfizer Prod Inc | Disperções farmacêuticas sólidas com biodisponibilidade melhorada |
| US6191160B1 (en) | 1998-11-10 | 2001-02-20 | Merck & Co., Inc. | Spiro-indolines as Y5 receptor antagonists |
| AR022044A1 (es) | 1999-05-06 | 2002-09-04 | Glaxo Group Ltd | Derivados de 1,5-benzodiazepina |
| US6462053B1 (en) | 1999-08-20 | 2002-10-08 | Banyu Pharmaceutical Co., Ltd. | Spiro compounds |
| TWI279402B (en) | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
| ES2249384T3 (es) | 2000-12-12 | 2006-04-01 | Neurogen Corporation | Espiro(isobenzofuran-1,4'-piperadin)-3-onas y 3h-espirobenzofuran-1,4-piperidinas. |
| US6924291B2 (en) | 2001-01-23 | 2005-08-02 | Merck & Co., Inc. | Process for making spiro isobenzofuranone compounds |
| US6605720B1 (en) | 2002-01-28 | 2003-08-12 | Merck & Co., Inc. | Process for making spirolactone compounds |
-
2005
- 2005-05-13 GE GEAP20059708A patent/GEP20094723B/en unknown
- 2005-05-13 CN CNA2005800147946A patent/CN1950374A/zh active Pending
- 2005-05-13 AU AU2005247693A patent/AU2005247693A1/en not_active Abandoned
- 2005-05-13 UA UAA200612379A patent/UA84208C2/ru unknown
- 2005-05-13 WO PCT/IB2005/001469 patent/WO2005116034A1/fr not_active Ceased
- 2005-05-13 AP AP2006003768A patent/AP2006003768A0/xx unknown
- 2005-05-13 CA CA002568056A patent/CA2568056A1/fr not_active Abandoned
- 2005-05-13 BR BRPI0510273-1A patent/BRPI0510273A/pt not_active IP Right Cessation
- 2005-05-13 EP EP05739440A patent/EP1753766A1/fr not_active Withdrawn
- 2005-05-13 JP JP2007514174A patent/JP4069159B2/ja not_active Expired - Fee Related
- 2005-05-13 EA EA200601773A patent/EA010888B1/ru not_active IP Right Cessation
- 2005-05-19 US US11/134,790 patent/US7265104B2/en not_active Expired - Fee Related
- 2005-05-20 GT GT200500119A patent/GT200500119A/es unknown
- 2005-05-23 AR ARP050102117A patent/AR049187A1/es not_active Application Discontinuation
- 2005-05-23 PE PE2005000568A patent/PE20060363A1/es not_active Application Discontinuation
- 2005-05-23 UY UY28915A patent/UY28915A1/es not_active Application Discontinuation
- 2005-05-24 PA PA20058634101A patent/PA8634101A1/es unknown
- 2005-05-24 TW TW094116913A patent/TWI297688B/zh active
- 2005-05-24 NL NL1029105A patent/NL1029105C2/nl not_active IP Right Cessation
- 2005-05-25 SV SV2005002127A patent/SV2006002127A/es not_active Application Discontinuation
-
2006
- 2006-09-20 IL IL178220A patent/IL178220A0/en unknown
- 2006-09-21 NO NO20064288A patent/NO20064288L/no not_active Application Discontinuation
- 2006-11-16 CR CR8753A patent/CR8753A/es not_active Application Discontinuation
- 2006-11-24 EC EC2006007025A patent/ECSP067025A/es unknown
- 2006-11-24 TN TNP2006000386A patent/TNSN06386A1/fr unknown
- 2006-11-24 MA MA29486A patent/MA28605B1/fr unknown
-
2007
- 2007-07-20 US US11/780,988 patent/US7358242B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL178220A0 (en) | 2006-12-31 |
| PA8634101A1 (es) | 2006-06-02 |
| NL1029105A1 (nl) | 2005-11-30 |
| EA200601773A1 (ru) | 2007-06-29 |
| PE20060363A1 (es) | 2006-05-08 |
| BRPI0510273A (pt) | 2007-10-30 |
| TNSN06386A1 (fr) | 2008-02-22 |
| US7265104B2 (en) | 2007-09-04 |
| JP4069159B2 (ja) | 2008-04-02 |
| US20050267100A1 (en) | 2005-12-01 |
| NO20064288L (no) | 2006-10-23 |
| CR8753A (es) | 2006-12-13 |
| GT200500119A (es) | 2006-01-12 |
| AR049187A1 (es) | 2006-07-05 |
| GEP20094723B (en) | 2009-07-10 |
| JP2008500326A (ja) | 2008-01-10 |
| EP1753766A1 (fr) | 2007-02-21 |
| TWI297688B (en) | 2008-06-11 |
| ECSP067025A (es) | 2006-12-29 |
| UA84208C2 (en) | 2008-09-25 |
| AU2005247693A1 (en) | 2005-12-08 |
| UY28915A1 (es) | 2005-12-30 |
| MA28605B1 (fr) | 2007-05-02 |
| WO2005116034A1 (fr) | 2005-12-08 |
| EA010888B1 (ru) | 2008-12-30 |
| US7358242B2 (en) | 2008-04-15 |
| SV2006002127A (es) | 2006-02-15 |
| US20070265193A1 (en) | 2007-11-15 |
| CN1950374A (zh) | 2007-04-18 |
| CA2568056A1 (fr) | 2005-12-08 |
| TW200609235A (en) | 2006-03-16 |
| NL1029105C2 (nl) | 2006-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2006003768A0 (en) | TetraazabenzoÄeÜazulene derivatives and analogs tehereof | |
| TWI369356B (en) | Tetrahydropyridoindole derivatives | |
| IL180481A0 (en) | Aryl-pyridine derivatives | |
| PT1802579E (pt) | Derivados da 3-arilaminopiridina | |
| EP1773871A4 (fr) | Composés associés au facteur de différenciation tissulaire et leurs analogues | |
| IL211894A0 (en) | Amide derivatives | |
| IL179736A0 (en) | Pyrrazolo-pyrimidine derivatives | |
| IL183657A0 (en) | Amide derivatives | |
| IL182585A0 (en) | Imidazo-benzodiazepine derivatives | |
| IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
| IL183142A0 (en) | New pyridothienopyrimidine derivatives | |
| IL182739A0 (en) | Acylatednonadepsipeptides used as lysobactin derivatives | |
| AP2074A (en) | New 4-benzylidene-piperidin derivatives | |
| IL183141A0 (en) | New pyridothienopyrimidine derivatives | |
| GB0414272D0 (en) | OsK1 derivatives | |
| IL177204A0 (en) | Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives | |
| IL178888A0 (en) | Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives | |
| IL179444A0 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
| TWI346109B (en) | 4-amino-5-cyanopyrimidine derivatives | |
| IL182001A0 (en) | 2-acylaminothiazole derivatives | |
| ZA200705150B (en) | Amide derivatives | |
| GB0405905D0 (en) | Azaquinazoline derivatives | |
| GB0422397D0 (en) | 3-Cyano-Quinoline derivatives | |
| HUP0402371A2 (en) | Novel 125-i-labeled amino-quinoline derivatives | |
| HU0400173V0 (en) | Medicinal chair-cushion |